Insider trade

Director sold ~$34K of AGX shares in the open market

Traded Dec 23, 2025 · Filed Dec 29, 2025

Why it stands out

A board member of Argan sold $34K of Argan shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

DirectorIndirect holding$25K–$100K

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$33,701

Shares × reported transaction price

Timing vs results

19 days after results of Dec 4, 2025, 93 days before results of Mar 26, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+4.8%	+0.7%	+4.0%
30 days	+12.7%	+1.0%	+11.7%
90 days	+62.9%	−8.0%	+71.0%
180 days	+150.9%	+7.9%	+143.1%

Past results only. Not a forecast.

On December 23, 2025, the Emily K. Leimkuhler Trust, of which the Reporting Person serves as Trustee, sold 100 shares of the Issuer's common stock at a price of $337.01 per share in an open market transaction.

Director sold

9mo ago

A board member of Argan sold $7.35M of Argan shares. Nobody planned it ahead of time.

9mo ago

Derivative exercise or conversion — not an open-market buy.

Director sold

9mo ago

A board member of Argan sold $1.03M of Argan shares. Nobody planned it ahead of time.